BMS-770767

DB18902InvestigationalSmall molecule

BMS-770767 is under investigation in clinical trial NCT01058083 (Safety Study of BMS-770767 in Subjects With Hypercholesterolemia).

Chemical structure of BMS-770767
Mechanism
Curator reviewed
Formula / weight
C19H18ClN3O2 · 355.82 g/mol (avg)
Also known as
4-(8-(2-CHLOROPHENOXY)(1,2,4)TRIAZOLO(4,3-A)PYRIDIN-3-YL)BICYCLO(2.2.1)HEPTAN-1-OL · BICYCLO(2.2.1)HEPTAN-1-OL, 4-(8-(2-CHLOROPHENOXY)-1,2,4-TRIAZOLO(4,3-A)PYRIDIN-3-YL)-
Code names
BMS-770767

Resolves to

Compound
UNII45T8YQ8DDWCAS1875067-34-7
Structure
InChIKeyHNXGIFYHJKEXNA-UHFFFAOYSA-NSMILESOC12CCC(CC1)(C2)C1=NN=C2N1C=CC=C2OC1=CC=CC=C1Cl
Targets
P28845HSD11B1

What you can answer from here — as of July 09, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
2Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with BMS-770767, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In